1 completed, 1 not yet recruiting, 1 unknown. 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Benzonatate 200 mg: new trials by email Literature Review of Benzonatate 200 mg trials Research Report on Benzonatate 200 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILD Gabapentin, Benzonatate 200 mg, Standard of care treatment for ILD - Interstitial Lung Disease | Phase 4 | Not yet recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 177 | 2026-10-07 | 2026-10-08 |
| A Study on the Efficacy and Safety of Benzonatate Soft Capsules for Improving Adult Cough Symptoms Benzonatate 200 mg, blank control 0mg - Cough | Phase 3 | Unknown | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 220 | 2018-03-01 | 2018-10-29 |
| Evaluation of the Effect of Benzonatate on QT Intervals Following Single Dose Administration of Benzonatate to Healthy Volunteers Benzonatate 200 mg, Benzonatate 800 mg, Moxifloxacin 400 mg - Healthy Volunteers | Phase 1 | Completed | Pfizer | 68 | 2014-05-01 | 2014-08-04 |
Cough (2) · Alveolitis, Extrinsic Allergic (1) · Lung Diseases, Interstitial (1) · Pulmonary Fibrosis (1) · Sarcoidosis (1)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · Pfizer (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1)
China (1) · India (1) · United States (1)
Cao Zhaolong, M.D. (1) · Sahajal Dhooria, MD, DM (1)